Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34+ cells

Experimental Cell Research

Volumn 318, Issue 3, 2012, Pages 196-206

  Wang, Xingbing ^a   Cheng, Qiansong ^a   Li, Lailing ^a   Wang, Jian ^a   Xia, Liang ^a   Xu, Xiucai ^a   Sun, Zimin ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Hematopoiesis; Human; Mesenchymal stromal cells; Toll like receptors

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 8; MESSENGER RNA; STEM CELL FACTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ADIPOGENESIS; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STROMAL CELL; CD34 CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL TYPE; COLONY FORMATION; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

EID: 84855834035     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.11.001     Document Type: Article

References (40)

1. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
2. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
3. Charbord P. Bone marrow mesenchymal stem cells: historical overview and concepts. Hum. Gene Ther. 2010, 21:1045-1056.
4. Oreffo R.O., Cooper C., Mason C., Clements M. Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential. Stem Cell Rev. 2005, 1:169-178.
5. Zipori D. Stromal cells from the bone marrow: evidence for a restrictive role in regulation of hemopoiesis. Eur. J. Haematol. 1989, 42:225-232.
6. Wagner W., Roderburg C., Wein F., Diehlmann A., Frankhauser M., Schubert R., Eckstein V., Ho A.D. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 2007, 25:2638-2647.
7. Méndez-Ferrer S., Michurina T.V., Ferraro F., Mazloom A.R., Macarthur B.D., Lira S.A., Scadden D.T., Ma'ayan A., Enikolopov G.N., Frenette P.S. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
8. Walenda T., Bork S., Horn P., Wein F., Saffrich R., Diehlmann A., Eckstein V., Ho A.D., Wagner W. Co-culture with mesenchymal stromal cells increases proliferation and maintenance of haematopoietic progenitor cells. J. Cell. Mol. Med. 2010, 14:337-350.
9. Robinson S.N., Simmons P.J., Yang H., Alousi A.M., Marcos de Lima J., Shpall E.J. Mesenchymal stem cells in ex vivo cord blood expansion. Best Pract. Res. Clin. Haematol. 2011, 24:83-92.
10. Kim D.W., Chung Y.J., Kim T.G., Kim Y.L., Oh I.H. Cotransplantation of third party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004, 103:1941-1948.
11. Le Blanc K., Samuelsson H., Gustafsson B., Remberger M., Sundberg B., Arvidson J., Ljungman P., Lönnies H., Nava S., Ringdén O. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 2007, 21:1733-1738.
12. Le Blanc K., Rasmusson I., Sundberg B., Götherström C., Hassan M., Uzunel M., Ringdén O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004, 363:1439-1441.
13. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M.E., Remberger M., Dini G., Egeler R.M., Bacigalupo A., Fibbe W., Ringdén O. Developmental Committee of the European Group for Blood and Marrow Transplantation, mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371:1579-1586.
14. Pontikoglou C., Deschaseaux F., Sensebé L., Papadaki H.A. Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev. 2011, 7:569-589.
15. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 2007, 213:341-347.
16. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
17. Cook D.N., Pisetsky D.S., Schwartz D.A. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 2004, 5:975-979.
18. Kumar H., Kawai T., Akira S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 2011, 30:16-34.
19. Yu L., Wang L., Chen S. Endogenous toll-like receptor ligands and their biological significance. J. Cell. Mol. Med. 2010, 14:2592-2603.
20. Zhang Z., Schluesener H.J. Mammalian toll-like receptors: from endogenous ligands to tissue regeneration. Cell. Mol. Life Sci. 2006, 63:2901-2907.
21. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
22. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999, 11:443-451.
23. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
24. Hwa Cho H., Bae Y.C., Jung J.S. Role of toll-like receptors on human adipose-derived cells. Stem Cells 2006, 24:2744-2752.
25. Pevsner-Fischer M., Morad V., Cohen-Sfady M., Rousso-Noori L., Zanin-Zhorov A., Cohen S., Cohen I.R., Zipori D. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007, 109:1422-1432.
26. Liotta F., Angeli R., Cosmi L., Filì L., Manuelli C., Frosali F., Mazzinghi B., Maggi L., Pasini A., Lisi V., Santarlasci V., Consoloni L., Angelotti M.L., Romagnani P., Parronchi P., Krampera M., Maggi E., Romagnani S., Annunziato F. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T cell modulatory activity by impairing Notch signaling. Stem Cells 2008, 26:279-289.
27. Opitz C.A., Litzenburger U.M., Lutz C., Lanz T.V., Tritschler I., Köppel A., Tolosa E., Hoberg M., Anderl J., Aicher W.K., Weller M., Wick W., Platten M. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2, 3-dioxygenase-1 via interferon-beta, and protein kinase R. Stem Cells 2009, 27:909-919.
28. Tomchuck S.L., Zwezdaryk K.J., Coffelt S.B., Waterman R.S., Danka E.S., Scandurro A.B. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 2008, 26:99-107.
29. Romieu-Mourez R., François M., Boivin M.N., Bouchentouf M., Spaner D.E., Galipeau J. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J. Immunol. 2009, 182:7963-7973.
30. Nagai Y., Garrett K.P., Ohta S., Bahrun U., Kouro T., Akira S., Takatsu K., Kincade P.W. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 2006, 24:801-812.
31. De Luca K., Frances-Duvert V., Asensio M.J., Ihsani R., Debien E., Taillardet M., Verhoeyen E., Bella C., Lantheaume S., Genestier L., Defrance T. The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate. Leukemia 2009, 23:2063-2074.
32. Wagner W., Ho A.D., Zenke M. Different facets of aging in human mesenchymal stem cells. Tissue Eng. Part B Rev. 2010, 16:445-453.
33. Jing D., Fonseca A.V., Alakel N., Fierro1 F.A., Muller K., Bornhauser M., Ehninger G., Corbeil D., Ordemann R. Hematopoietic stem cells in co-culture with mesenchymal stromal cells - modeling the niche compartments in vitro. Haematologica 2010, 95:542-550.
34. + peripheral blood progenitor cells and decrease their allostimulatory capacity. Exp. Hematol. 2007, 35:507-515.
35. Fei X.M., Wu Y.J., Chang Z., Miao K.R., Tang Y.H., Zhou X.Y., Wang L.X., Pan Q.Q., Wang C.Y. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice. Cytotherapy 2007, 9:338-347.
36. Wieland C.W., van Lieshout M.H.P., Hoogendijk A.J., van der Poll T. Host defence during Klebsiella pneumonia relies on haematopoietic-expressed Toll-like receptors 4 and 2. Eur. Respir. J. 2011, 37:848-857.
37. Kelly S.S., Parmar S., De Lima M., Robinson S., Shpall E. Overcoming the barriers to umbilical cord blood transplantation. Cytotherapy 2010, 12:121-130.
38. Walenda T., Bokermann G., Ventura Ferreira M.S., Piroth D.M., Hieronymus T., Neuss S., Zenke M., Ho A.D., Müller A.M., Wagner W. Synergistic effects of growth factors and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells. Exp. Hematol. 2011, 39:617-628.
39. Andrade P.Z., dos Santos F., Almeida-Porada G., da Silva C.L., Cabral J.M.S. Systematic delineation of optimal cytokine concentrations to expand hematopoietic stem/progenitor cells in co-culture with mesenchymal stem cells. Mol. Biosyst. 2010, 6:1207-1215.
40. Lorimore S.A., Coates P.J., Wright E.G. Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene 2003, 22:7058-7069.